Hawkinson Russ 4
4 · Silverback Therapeutics, Inc. · Filed Dec 8, 2020
Insider Transaction Report
Form 4
Hawkinson Russ
Sr. Vice President of Finance
Transactions
- Purchase
Common Stock
2020-12-08$21.00/sh+238$4,998→ 238 total
Footnotes (1)
- [F1]The shares were purchased in the Issuer's initial public offering.